Skip to main content
Top
Published in: Clinical Rheumatology 7/2019

01-07-2019 | Arthritis | Brief Report

Are extra-spinal symptoms associated with quality of life in patients with axial spondyloarthritis? A 1-year follow-up study

Authors: Yu Heng Kwan, Warren Fong, Ying Ying Leung, Nai Lee Lui, Chuen Seng Tan, Rahul Malhotra, Truls Østbye, Julian Thumboo

Published in: Clinical Rheumatology | Issue 7/2019

Login to get access

Abstract

To assess the extent to which a history of extra-spinal symptoms (including peripheral arthritis, heel enthesitis, or dactylitis) (HPED) is associated with quality of life (QoL) in patients with axial spondyloarthritis (axSpA) at baseline and 1-year follow-up. We analyzed data from 138 patients with axSpA from a tertiary referral center in Singapore, seen between 2011 and 2015. Demographic, clinical variables, and patient-reported outcomes [Ankylosing Spondylitis Quality of Life (ASQoL) and SF-36] at baseline and 1-year follow-up were collected. We used linear mixed models to assess the association of HPED with QoL at baseline and 1 year post-baseline. Among 138 patients (mean age 39.3 years, 74.6% males, 87.6% Chinese, disease duration 7.4 years), at baseline, HPED was associated with poorer QoL for 3 of 8 SF-36 domains [role physical (RP) scores β − 8.38, p < 0.05; social functioning (SF) scores β − 6.74, p < 0.05; role emotional (RE) scores β − 9.37, p < 0.01] and SF-36 Physical Component Summary (PCS) (β − 4.52, p < 0.01) scores, but not ASQoL scores. At 1 year post-baseline, HPED was associated with poorer ASQoL (β 1.61, p < 0.05) scores, SF-36 PCS (β − 5.61, p < 0.01) scores, and three out of eight SF-36 domains (physical functioning (PF) β − 9.60, p < 0.01; RP β − 12.17, p < 0.01; RE β − 7.87, p < 0.05) scores. HPED was associated with QoL in patients with axSpA. After 1-year, patients with HPED have poorer QoL especially for physical health domains than patients without HPED.
Appendix
Available only for authorised users
Literature
4.
go back to reference van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Geher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compan V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://doi.org/10.1136/annrheumdis-2016-210770 CrossRefPubMed van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Geher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compan V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://​doi.​org/​10.​1136/​annrheumdis-2016-210770 CrossRefPubMed
5.
go back to reference Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Jama 273(1):59–65CrossRefPubMed Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Jama 273(1):59–65CrossRefPubMed
7.
go back to reference Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27(3 Suppl):S217–S232CrossRefPubMed Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27(3 Suppl):S217–S232CrossRefPubMed
9.
go back to reference Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewe R, Maksymowych W, van der Heijde D (2009) The assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–i44. https://doi.org/10.1136/ard.2008.104018 CrossRefPubMed Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewe R, Maksymowych W, van der Heijde D (2009) The assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–i44. https://​doi.​org/​10.​1136/​ard.​2008.​104018 CrossRefPubMed
10.
go back to reference Yilmaz O, Tutoglu A, Garip Y, Ozcan E, Bodur H (2013) Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatol Int 33(5):1159–1163. https://doi.org/10.1007/s00296-012-2510-5 CrossRefPubMed Yilmaz O, Tutoglu A, Garip Y, Ozcan E, Bodur H (2013) Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatol Int 33(5):1159–1163. https://​doi.​org/​10.​1007/​s00296-012-2510-5 CrossRefPubMed
11.
go back to reference Kwan YH, Fong W, Leung YY, Tan VIC, Yap AF, Lui NL, Phang JK, Yoon S, Malhotra R, Thumboo J, Ostbye T (2018) A qualitative study of Quality of Life domains and subdomains relevant to patients with Spondyloarthritis International journal of rheumatic diseases Kwan YH, Fong W, Leung YY, Tan VIC, Yap AF, Lui NL, Phang JK, Yoon S, Malhotra R, Thumboo J, Ostbye T (2018) A qualitative study of Quality of Life domains and subdomains relevant to patients with Spondyloarthritis International journal of rheumatic diseases
18.
go back to reference Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: ankylosing spondylitis disease activity score (ASDAS), ankylosing spondylitis quality of life scale (ASQoL), Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI), Bath ankylosing spondylitis global score (BAS-G), Bath ankylosing spondylitis metrology index (BASMI), Dougados functional index (DFI), and health assessment questionnaire for the spondylarthropathies (HAQ-S). Arthritis Care Res 63(Suppl 11):S47–S58. https://doi.org/10.1002/acr.20575 CrossRef Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: ankylosing spondylitis disease activity score (ASDAS), ankylosing spondylitis quality of life scale (ASQoL), Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI), Bath ankylosing spondylitis global score (BAS-G), Bath ankylosing spondylitis metrology index (BASMI), Dougados functional index (DFI), and health assessment questionnaire for the spondylarthropathies (HAQ-S). Arthritis Care Res 63(Suppl 11):S47–S58. https://​doi.​org/​10.​1002/​acr.​20575 CrossRef
19.
go back to reference Sow WT, Wee HL, Wu Y, Tai ES, Gandek B, Lee J, Ma S, Heng D, Thumboo J (2014) Normative data for the Singapore English and Chinese SF-36 version 2 health survey. Ann Acad Med Singap 43(1):15–23PubMed Sow WT, Wee HL, Wu Y, Tai ES, Gandek B, Lee J, Ma S, Heng D, Thumboo J (2014) Normative data for the Singapore English and Chinese SF-36 version 2 health survey. Ann Acad Med Singap 43(1):15–23PubMed
20.
go back to reference Fernandez-Carballido C, Navarro-Compan V, Castillo-Gallego C, Castro-Villegas MC, Collantes-Estevez E, de Miguel E (2017) Disease activity as a major determinant of quality of life and physical function in patients with early axial spondyloarthritis. Arthritis Care Res 69(1):150–155. https://doi.org/10.1002/acr.22908 CrossRef Fernandez-Carballido C, Navarro-Compan V, Castillo-Gallego C, Castro-Villegas MC, Collantes-Estevez E, de Miguel E (2017) Disease activity as a major determinant of quality of life and physical function in patients with early axial spondyloarthritis. Arthritis Care Res 69(1):150–155. https://​doi.​org/​10.​1002/​acr.​22908 CrossRef
21.
go back to reference van der Heijde D, Dougados M, Landewe R, Sieper J, Maksymowych WP, Rudwaleit M, Van den Bosch F, Braun J, Mease PJ, Kivitz AJ, Walsh J, Davies O, Bauer L, Hoepken B, Peterson L, Deodhar A (2017) Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. Rheumatology (Oxford, England) 56(9):1498–1509. https://doi.org/10.1093/rheumatology/kex174 CrossRef van der Heijde D, Dougados M, Landewe R, Sieper J, Maksymowych WP, Rudwaleit M, Van den Bosch F, Braun J, Mease PJ, Kivitz AJ, Walsh J, Davies O, Bauer L, Hoepken B, Peterson L, Deodhar A (2017) Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. Rheumatology (Oxford, England) 56(9):1498–1509. https://​doi.​org/​10.​1093/​rheumatology/​kex174 CrossRef
22.
24.
go back to reference Lopez-Medina C, Garrido-Castro JL, Castro-Jimenez J, Gonzalez-Navas C, Calvo-Gutierrez J, Castro-Villegas MC, Ortega-Castro R, Escudero-Contreras A, Font-Ugalde P, Collantes-Estevez E (2018) Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage. Clin Rheumatol 37(6):1581–1588. https://doi.org/10.1007/s10067-018-4112-4 CrossRefPubMed Lopez-Medina C, Garrido-Castro JL, Castro-Jimenez J, Gonzalez-Navas C, Calvo-Gutierrez J, Castro-Villegas MC, Ortega-Castro R, Escudero-Contreras A, Font-Ugalde P, Collantes-Estevez E (2018) Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage. Clin Rheumatol 37(6):1581–1588. https://​doi.​org/​10.​1007/​s10067-018-4112-4 CrossRefPubMed
30.
Metadata
Title
Are extra-spinal symptoms associated with quality of life in patients with axial spondyloarthritis? A 1-year follow-up study
Authors
Yu Heng Kwan
Warren Fong
Ying Ying Leung
Nai Lee Lui
Chuen Seng Tan
Rahul Malhotra
Truls Østbye
Julian Thumboo
Publication date
01-07-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04514-4

Other articles of this Issue 7/2019

Clinical Rheumatology 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine